US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.7950
  • +0.0350+1.99%
Trading Dec 19 11:01 ET
391.64MMarket Cap-8.16P/E (TTM)

Akebia Therapeutics Key Stats

Business Currency:USD
2024/Q3
Stock NameRevenueRatio
Product revenue, net35.59M95.09%
License, collaboration and other revenue1.84M4.91%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States194.62M100.00%
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.